What's in Iroko Pharmaceuticals, LLC's pipeline?

Iroko Pharmaceuticals, LLC has 7 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 5 in Phase 2, 0 in Phase 1.

Which companies overlap with Iroko Pharmaceuticals, LLC's portfolio?

Top competitors by shared drug class: Organon and Co, Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division, Noven Pharmaceuticals, Inc., Amneal Pharmaceuticals, LLC, Pfizer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/iroko-pharmaceuticals-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Iroko Pharmaceuticals, LLC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Iroko Pharmaceuticals, LLC pipeline: 0 marketed, 0 filed, 2 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 5 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Diclofenac Test (lower dose)	Diclofenac Test (lower dose)	phase 3	Nonsteroidal anti-inflammatory drug (NSAID)	COX-1 and COX-2	Pain Management / Rheumatology
Diclofenac Test (upper dose)	Diclofenac Test (upper dose)	phase 3	Nonsteroidal anti-inflammatory drug (NSAID)	COX-1 and COX-2	Pain Management / Rheumatology

Therapeutic area mix

Rheumatology · 3
Pain Management / Rheumatology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Organon and Co · 2 shared drug classes
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division · 2 shared drug classes
Noven Pharmaceuticals, Inc. · 2 shared drug classes
Amneal Pharmaceuticals, LLC · 2 shared drug classes
Pfizer · 2 shared drug classes
Antibe Therapeutics Inc. · 1 shared drug class
Amzell · 1 shared drug class
Allergan · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Iroko Pharmaceuticals, LLC:

Cite this brief

Drug Landscape (2026). Iroko Pharmaceuticals, LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/iroko-pharmaceuticals-llc. Accessed 2026-06-10.